April 3, 2026·8 min read·primer, manufacturing
How peptides are made — synthesis 101
From amino acids to vial: solid-phase synthesis, coupling chemistry, cleavage, and purification.
From amino acids to vial: solid-phase synthesis, coupling chemistry, cleavage, and purification.
A peptide is a chain of amino acids linked by peptide bonds. Getting that chain off the lab bench and into a vial requires precision chemistry and multiple rounds of purification. The most common path is solid-phase peptide synthesis, a technique developed by Bruce Merrifield in 1963 and awarded the Nobel Prize in 1984. It's the backbone of modern peptide manufacturing. Understanding the synthesis process is foundational to evaluating what research-grade peptides mean and learning to read a Certificate of Analysis.
The idea is elegant: anchor one end of a growing peptide chain to a resin bead, then build the chain outward amino acid by amino acid. Each amino acid arrives pre-activated and protected with chemistry that prevents unwanted side reactions. You add it to the bead, wash away excess, deprotect, and repeat. Once the full sequence is built, you cleave the peptide from the bead, purify the result, and test it.
The resin bead itself is inert polystyrene, roughly 50–200 micrometers in diameter. It's chosen because it's insoluble (easy to filter and wash between steps), chemically robust (survives the organic solvents in the synthesis), and can be functionalized to anchor different peptide classes. Most modern manufacturing uses Rink amide or HPLC-C18 functionalizations. These manufacturing standards directly inform how you evaluate the compounds you purchase — a topic central to understanding what research-grade peptides mean.
Fmoc (9-fluorenylmethoxycarbonyl) is the industry standard for research and custom synthesis. The Fmoc group protects the amino terminus (the "free end" ready to couple to the next amino acid). Once coupled, you deprotect by removing the Fmoc with base (typically 20% piperidine in DMF), exposing the free amine and priming it for the next coupling. Fmoc is base-labile — removed with a chemical base — and leaves no residue that interferes with downstream chemistry.
Boc (tert-butyloxycarbonyl) is the older method, still used in some high-volume pharmaceutical manufacturing. It protects the same way, but it's removed with acid (typically 55% TFA in DCM), not base. Boc is more robust in some solvent systems but generates more waste and leaves trace acid artifacts. For this reason, Fmoc dominates modern research-peptide manufacturing. The coupling chemistry also determines the residual solvents you'll see declared on a Certificate of Analysis.
Each amino acid addition follows the same cycle. You start with your growing chain on the bead, protected at the free amine by an Fmoc group (or Boc, depending on method).
First: deprotect. Strip the Fmoc (or Boc) in 2–5 minutes with base (or acid). Wash thoroughly — any residual deprotecting agent will poison the next coupling.
Second: couple. Add the next amino acid (pre-activated as an ester or carbodiimide) plus a coupling catalyst (typically DCC and HOBt, or a uronium salt like HBTU). The activated amino acid's carbonyl reacts with the free amine on your growing chain. This step typically runs 15–60 minutes. Coupling efficiency is typically 95–99.5% per cycle, which sounds high until you do the math: a 30-residue peptide built with 97% per-cycle efficiency ends with a final product yield of roughly (0.97)^30 ≈ 41% by-weight accounting for losses to incomplete couplings alone.
Third: wash. DMSO, DCM, or ethanol — whatever removes excess coupling reagents without damaging the protecting groups or the resin.
Repeat 10–100 times depending on the peptide length.
Once the full sequence is built, you need to remove the peptide from the resin and remove all the protecting groups (side-chain protections that kept the amino acids from reacting with themselves during synthesis). For Fmoc synthesis, this is typically done with TFA (trifluoroacetic acid), often mixed with water and other "scavengers" (like phenol or triisopropylsilane) to mop up reactive carbocation intermediates generated during deprotection. The reaction is aggressive — you dissolve the resin beads completely in 2–4 hours of strong acid, then precipitate the crude peptide with cold ether or isopropanol. You filter, dry, and now have crude peptide.
For Boc synthesis, cleavage is done with HF (hydrofluoric acid), a much more hazardous reagent. The resulting crude peptide is similar, but HF-based cleavages generate different scavenger by-products and require specialized equipment.
Crude peptide is a mixture of target, deletion sequences (where a coupling failed), branched products, and coupling-reagent residues. Purification by reverse-phase HPLC is the industry standard. A C18 column is loaded with the crude peptide in aqueous acetonitrile (5–10% organic). You run a gradient to 95% acetonitrile over 20–60 minutes, and the peptide elutes based on hydrophobicity. The target peptide (assuming it was designed correctly) elutes at a predictable time — typically 20–40 minutes into the run.
You collect the peak, evaporate the solvent (rotary evaporation or lyophilization), and now have purified peptide. Research-grade synthesis typically targets ≥98% purity by HPLC. Pharmaceutical-grade targets ≥99.5%.
Once you have purified lyophilized peptide, you confirm it is what you think it is. Mass spectrometry (MALDI or ESI) measures the molecular weight to within ±1 Da, confirming the amino-acid sequence. A 31-residue peptide should weigh exactly 3,566.4 Da (example); if you measure 3,585.2, something went wrong — a wrong amino acid was incorporated, or an unexpected modification occurred.
HPLC-MS combines the two: you run the peptide through HPLC, and as each peak elutes, you measure its mass. This catches impurities, co-eluting sequences, and oxidation products (e.g. methionine sulfoxide if methionine is in your sequence).
Water content is measured by Karl Fischer titration — typical research-grade lyophilized peptides contain 3–10% residual water. Endotoxin (LAL assay) is typically less than 10 EU/mg for research-grade; pharmaceutical typically less than 1 EU/mg.
The chemistry of the synthetic route is identical. A 5 mg vial of research-grade GLP-1 peptide from a reputable vendor and the same molecule in a pharmaceutical vial are the same compound. The difference is process control and documentation.
Research-grade peptides are synthesized in non-cGMP labs, often with smaller batches, less documentation, and looser supplier qualification. Impurity profiles may not be fully characterized. A research-grade vendor will provide a COA (Certificate of Analysis) with purity, identity, and basic testing, but not necessarily residual-solvent assays or in-process controls.
Pharmaceutical-grade (cGMP) peptides are made in facilities audited by regulators, with batch records documenting every step, supplier validation for every reagent, in-process controls, and extensive post-release testing including residual solvents, microbial limits, and stability data. A pharmaceutical batch is traceable. A research batch is often not.
For research use, the difference matters less than the vendor's reputation. A reputable research supplier (with published COAs and third-party HPLC verification) often delivers higher real-world purity than the regulatory distance suggests.
China dominates wholesale bulk peptide synthesis — both research-grade contract synthesis and the raw amino acids that feed all other synthesis. US and EU contract manufacturers handle custom orders, pharmaceutical-grade work, and high-purity specialty sequences. This geography exists because labor costs in China scale to high-volume amino-acid manufacturing and basic research synthesis; European and North American labs specialize in validation, QA, and regulatory work.
A peptide marketed as "made in the USA" may contain Chinese-sourced amino acids, Chinese-synthesized precursors, and only finishing/testing in a US lab. Read the COA and trace the supplier chain if that matters to you.
Peptides are not cheap to synthesize. A custom 30-residue peptide from a legitimate vendor costs $200–1,000 depending on purity, sequence complexity (cysteines require disulfide chemistry), and volume. A vial offered at $30 with no COA, no purity spec, no mass-spec confirmation, and no identifiable manufacturer is either counterfeit, heavily degraded, or mislabeled. The HPLC run alone costs $100–300 for an outside lab.
Legitimate vendors publish lot-specific COAs. If you can't access one before purchase — or if the vendor says "COAs are available upon request" but never deliver — you have no basis to trust the identity or purity of what you're buying.